Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder

GLE/PIB may be an effective treatment for PTSD. Furthermore, treatment may modulate inflammatory responses in PTSD. Future studies are required to confirm these findings regarding GLE/PIB, PTSD, and inflammation.

Authors

Institutions

Publication Details

Journal
Psychopharmacology Bulletin
Published
2025-12-22
DOI
https://doi.org/10.64719/pb.15419
Primary Topic
Posttraumatic Stress Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder

Jessica E. Hoyt, Luke Rozema, Crystal M. Noller, Krista D. DiSano et al.
Psychopharmacology Bulletin
Posttraumatic Stress Disorder Research
article

Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder

Jessica E. Hoyt, Luke Rozema, Crystal M. Noller, Krista D. DiSano, Matthew P. Vincenti, Brian Shiner, Danielle M. Foster, Bradley V. Watts
article en

Abstract

GLE/PIB may be an effective treatment for PTSD. Furthermore, treatment may modulate inflammatory responses in PTSD. Future studies are required to confirm these findings regarding GLE/PIB, PTSD, and inflammation.

Psychopharmacology BulletinVol. 56(1)
White River Junction VA Medical Center (US)
Good health and well-being
Openalex Percentile: Top 25%
Posttraumatic Stress Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.